The urgent need for an effective biomarker for cytotoxic therapy-induced adverse effects

Curr Opin Support Palliat Care. 2013 Jun;7(2):153-4. doi: 10.1097/SPC.0b013e32835e7f73.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Biomarkers*
  • Breath Tests
  • Citrulline / metabolism
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Intestinal Mucosa / injuries*
  • Leukocyte L1 Antigen Complex / metabolism
  • Radiotherapy / adverse effects*
  • Toxicity Tests*

Substances

  • Antineoplastic Agents
  • Biomarkers
  • Leukocyte L1 Antigen Complex
  • Citrulline